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In this study, we examined desmoglein (Dsg) 3 and
other desmosomal molecules after pemphigus vulgaris
(PV)-immunoglobulin G (IgG) binding to the Dsg3
on the cell surface in DJM-1 cells, a human squamous
cell carcinoma cell line. After cells were incubated
with PV-IgG for various time periods (0, 5, 10, 20, 30,
60 min, or 30 h), cells were fractionated into phosphate-
buffered saline soluble (cytosol), phosphate-buffered
saline insoluble-Triton X-100 soluble (membrane), and
Triton X-100 insoluble (cytoskeleton) fractions, and
subjected to immunoblotting and immunofluores-
cence microscopy using antibodies against Dsg1, Dsg3,
plakoglobin, desmoplakin 1, and cytokeratins. Immu-
noblot analysis with PV-IgG revealed that Dsg3 was
already dramatically depleted from the membrane
fraction 20 min after PV-IgG treatment, whereas no
Pemphigus vulgaris (PV) and pemphigus foliaceus areautoimmune skin diseases in which loss of adhesionbetween keratinocytes (i.e., acantholysis) appears to bemediated by binding of autoantibodies against desmogl-ein (Dsg) 3 (Eyre and Stanley, 1988; Hashimoto et al,
1990; Buxton et al, 1993) and Dsg1 (Koulu et al, 1984; Andrew
et al, 1995), respectively. These target molecules of autoantibodies,
Dsg3 and Dsg1, are core proteins of desmosome (Eyre and Stanley,
1988; Karpati et al, 1993), which form a 210 kDa or a 240 kDa
protein complex by association with plakoglobin (PG), respectively
(Korman et al, 1985). Although it is now widely accepted that
autoantibodies against Dsg3 and Dsg1 are the primary pathogenic
agents (Amagai, 1995), the key question concerning the exact
mechanism for acantholysis after PV- or pemphigus foliaceus-
immunoglobulin G (IgG) binding to the antigens on the cell surface
has not yet been elucidated. Pemphigus-induced acantholysis may
be caused either by proteinases from keratinocytes (Morioka et al,
1981), such as plasminogen activator (Hashimoto et al, 1983), or
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reduction of Dsg3 was detected in the cytoskeleton
fraction as examined by immunoblotting. A 30 h
incubation with PV-IgG, however, caused a marked
disappearance of Dsg3, but not other desmosomal
molecules, from cytoskeleton fractions. Furthermore,
double-staining immunofluorescence microscopy
revealed that Dsg3 was depleted from the desmosomes
whereas Dsg1, desmoplakin 1, plakoglobin, and keratin
filaments were bound to desmosomes. These results
provide a novel interpretation for a better understand-
ing of mechanisms for blistering in PV; i.e., a possibil-
ity that PV-IgG generates the formation of aberrant
desmosomes, which are lacking in Dsg3, but not
other desmosomal constituents. Key words: autoimmune
blistering disease/desmoplakin/keratin intermediate fila-
ment/plakoglobin. J Invest Dermatol 112:67–71, 1999
possibly by direct binding of PV-IgG to desmosomal molecules to
disrupt cell–cell attachment (Koch et al, 1997). We have previously
demonstrated that the Ca11-induced desmosome formation gener-
ated by a change from low (,0.09 mM) to high (.1.0 mM) Ca11
concentration, was not inhibited by PV-IgG binding to the surface
PV antigen. Desmosomal bridges, however, which were formed
following the change in Ca11 concentration, in the presence of
PV-IgG, were dissociated within 24–36 h after PV-IgG binding to
the cell surface (Kitajima et al, 1987). This time lag of 24–36 h to
produce cell–cell detachment suggests that any cell biologic response
leading to cell detachment may be involved, rather than be a direct
inhibition of desmosome formation.
From these viewpoints, we have recently studied the effects
of PV-IgG on the intracellular signal transduction events and
demonstrated that PV-IgG binding to DJM-1 cells (a squamous
cell carcinoma line) induces a transient increase in activation of
phospholipase C (Esaki et al, 1995) and increased inositol 1,4,5-
trisphosphate production, with a concomitant increase in intracellu-
lar calcium concentration ([Ca11]i) (Seishima et al, 1995), and
characteristic activation of diverse isomers of protein kinase C, a
family of Ca11- and phospholipid-dependent serine/threonine
kinase (Osada et al, 1997), linked to secretion of plasminogen
activators and expression of plasminogen activator receptor (Seish-
ima et al, 1997; reviewed in Kitajima, 1996).
In this study, we determined what happened to the desmosomal
constituents, Dsg1, Dsg3, PG, and desmoplakin (Dpk) 1, during
cell detachment induced by PV-IgG in cultured human transformed
keratinocytes, DJM-1 cells, by immunofluorescence microscopy
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and immunoblotting using antibodies against these desmosomal
constituents. The reason DJM-1 cells are used as an experimental
cell system for PV-IgG-cell detachment, is that this cell line has
been shown to be much more sensitive to the PV-IgG-induced
cell–cell detachment and the number of desmosomes has been
shown to be much smaller than with normal keratinocytes, so that
the effects of PV-IgG on desmosomes can be clearly detected in
morphology. Immunoblotting revealed that Dsg3 had already
disappeared from a pool, i.e., the phosphate-buffered saline (PBS)
insoluble-Triton X-100 soluble (membrane) fraction, before being
integrated into desmosomes 20 min after the addition of PV-IgG
in the culture medium, whereas Dsg3 associated with the Triton
X-100 insoluble (cytoskeleton) fraction had not. Surprisingly,
however, after 30 h incubation, Dsg3 was almost completely
deleted from cytoskeleton fractions, and this deletion was seen in
desmosomes as illustrated by immunofluorescence microscopy.
These data tempted us to speculate that PV-IgG may generate an
impaired epidermis, the desmosomes of which have abnormally
low Dsg3 levels.
MATERIALS AND METHODS
Antibodies Monoclonal antibody (PG5.1) against PG and monoclonal
antibody (DP2.17) against Dpk1 were obtained from Progen (Heidelberg,
Germany). Monoclonal antibody against Dsg1/2 and that against keratin
8 were obtained from Progen and DAKO (Carpinteria, CA), respectively.
Purification of IgG Sera from six patients with PV, and normal
volunteers without any skin disease, were used for these experiments. All
sera were heated to 56°C for 30 min to inactivate complement, and were
stored at –80°C. IgG fractions were isolated from these sera by using Mab
Trap GII kit (Pharmacia AB, Uppsala, Sweden). The purity of isolated
IgG was checked by electrophoresis.
Cell cultures An isolated cell line (DJM-1) from human skin squarnous
cell carcinoma was used in this study (Kitajima et al, 1987, 1988). Cells
were cultured in minimum essential medium (Life Technologies, Grand
Island, NY) containing 10% fetal calf serum, 0.4 mg hydrocortisone per
ml, 10 mg epidermal growth factor per ml, 84 ng cholera toxin per ml,
100 mg kanamycin per ml, and 1.8 mM Ca21. At 80%–90% confluence, cells
were exposed to PBS containing 0.25% trypsin and 10 mM ethylenediamine
tetraacetic acid for 10 min at 37°C. They were resuspended in minimum
essential medium with 10% fetal calf serum, cultured for 2 d, and used as
described below.
Treatment with PV-IgG and cell fractionation To determine what
happens to desmosomal constituents, cells were fractionated into PBS
soluble (cytosol), PBS insoluble-Triton X-100 soluble (membrane), and
Triton X-100 insoluble (cytoskeleton) fractions. After cells reached conflu-
ence, PV-IgG or normal IgG was directly added into the culture medium
at a final concentration of 0.3 mg per ml and cells were incubated for 0,
5, 10, 20, 30, 60 min, or 30 h. Because it was confirmed that complement-
inactivated sera (treated with 56°C for 30 min) exerted the same results as
purified IgG, repeating experiments were carried out with PV sera. Cells
were then washed twice with PBS and harvested with buffer A containing
1 mM phenylmethyisulfonyl fluoride (Sigma, St. Louis, MO) and 5 mM
E64 (Peptide Institute, Osaka, Japan) in PBS. After sonication (five times
for 5 s for each), cell homogenates were centrifuged at 105,000 3 g for
60 min. The supernatant was stored as the cytosol fraction at –80°C. The
pellet was solubilized with buffer A containing 1% Triton X-100 and
centrifuged at 105,000 3 g for 60 min. The resultant supernatant was
stored as the membrane fraction. The Triton X-100 insoluble pellet was
solubilized with 0.25 M Tris, pH 6.8, 2% sodium dodecyl sulfate, 30%
glycerol, and 10% β-mercaptoethanol, and stored as the cytoskeleton
fraction at –80°C. Protein concentrations were determined spectrophoto-
metrically using the Bio-Rad with protein assay kit (Bio-Rad, Rich-
mond, CA).
Immunoblotting Aliquots of the cytosol, membrane, and cytoskeleton
fractions were mixed with sample buffer (10% 2-β-mereaptoethanol,
2% sodium dodecyl sulfate, 30% glycerol, 0.25 M Tris, pH 6.8, final
concentration), and heated at 98°C for 5 min. Samples of each fraction
(30 µg of protein per lane) were subjected to reducing sodium dodecyl
sulfate-polyacrylamide gel electrophoresis 10% polyacrylamide gels by the
method of Laemmli (1970). Protein standards for molecular weight (Bio-
Rad) were as follows: ovalbumin, 49 kDa; bovine serum albumin, 80 kDa;
P-galactosidase, 116.5 kDa; and myosin, 205 kDa. Keratin 8 was used
as an internal standard to analyze semiquantitatively the desmosomal
constituents.
Immunofluorescence microscopy The cells cultured on the glass
coverslips were treated with PV-IgG or complement-inactivated sera
obtained from patients with PV or normal individuals for 20 min or 30 h.
The cells, on the coverslips, were rinsed with ice cold PBS and fixed
by dipping for 10 min in –20°C methanol, followed by incubation and
washing with PBS containing 0.05% Triton X-100. The fixed cells were
first incubated with PV sera overnight and stained with anti-human IgG
labeled rhodamine for 45 min after washing with PBS, and then incubated
for 2 h with one of the monoclonal antibodies directed to Dsg I, PG,
Dpk1, and cytokeratins, followed by staining with anti-mouse IgG labeled
with fluorescent isotiocloride (Cappel, Durham, NC) for 45 min. Controls
for specificity of the antibodies were routinely carried out. Photomicro-
graphs were taken with a Nikon FX-RFD photomicroscope (Nikon,
Tokyo, Japan).
Figure 1. Immunoblots of membrane (PBS insoluble-Triton X-100
soluble) fractions obtained after 20 min or 30 h stimulation with
PV-IgG (PV) or normal human IgG (Nor) in DJM-1 cells, using
anti-Dsg1, Dsg3, and plakoglobin (PG) antibodies. Dsg 3 was
depleted almost completely from membrane fractions 20 min and also 30 h
after PV-IgG stimulation, whereas normal IgG stimulation caused no
depletion of Dsg3. In contrast, Dsg1 and PG were not depleted at any
time after PV-IgG stimulation as well as normal IgG stimulation.
Figure 2. Immunoblots of cytoskeleton (Triton X-100 insoluble)
fractions obtained after 20 min or 30 h stimulation with PV-IgG
(PV) or normal human IgG (Nor) in DJM-1 cells, using anti-Dsg1,
Dsg3, Dpk1, PG, and keratin 8 (K8). Stimulation with PV-IgG for
30 h caused almost complete depletion of Dsg 3 from cytoskeleton fractions,
whereas Dsg1, Dpk1, and PG were not deleted by this stimulation. Note
that stimulation with PV-IgG for 20 min is not enough to cause depletion
of Dsg3, as is clearly demonstrated by comparing the densities of bands of
keratin 8 and Dsg3. Keratin 8 (K8) is used for a quantitative control.
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RESULTS
PV-IgG caused a depletion of Dsg3 from its pool and
cytoskeleton fractions as detected by immunoblotting Dsg1,
Dsg3, Dpk1, and PG were measured after cells were treated with
PV-IgG for 0, 5, 10, 20, 30, 60 min, and 30 h, because our
previous studies showed that phosphorylation of Dsg3 was caused
after 20 min treatment and cell–cell detachment was generated
after 30 h treatment with PV-IgG in DJM-1 cells. After cell
fractionation, aliquots of PBS soluble (cytosol), PBS insoluble-
Triton X-100 soluble (membrane), and Triton X-100 insoluble
(cytoskeleton) fractions were processed for immunoblotting with
antibodies against Dsg1, Dpk1, PG, and with PV-IgG for detection
of Dsg3. Immunoblots of cytoskeleton fractions were subjected to
double-staining with one of these antibodies and monoclonal
antibody to keratin 8 as an internal standard for semiquantitative
analysis.
The results showed that a marked reduction or an almost
complete disappearance of Dsg3, but not of Dsg1 or PG, from the
membrane fraction was seen 20–60 min and 30 h, although not at
0–10 min, after treatment with PV-IgG, whereas treatment with
normal IgG did not affect the amount of any of Dsg3, Dsg1, and
PG (Fig 1). In contrast to membrane fractions, no detectable
reduction of Dsg3, as well as of Dpk1 and PG, from the cytoskeleton
fractions was caused 20–60 min after treatment with PV-IgG. A
30 h treatment with PV-IgG, however, deleted Dsg3 almost
completely from the cytoskeleton fractions, whereas again it had
no affect on Dsg1, PG, and Dpk1. The reduction in the quantity
of Dsg3 was confirmed by comparing with the amount of keratin
8 as an internal standard after PV-IgG treatment (Fig 2). Normal
IgG also exerted no effects on any of Dsg1, Dsg3, PG, and Dpk1
in cytoskeleton fractions (Fig 2). Taken together, these results
imply that PV-IgG treatment substantially reduced the amount of
Dsg3 from the Triton X-100 soluble (membranes) pool early in
the experiment, i.e., after 20 min, and from the Triton X-100
insoluble (cytoskeletons) pool later in the experiment, i.e., after 30 h.
PV-IgG deleted Dsg3 from desmosomes as revealed by
immunofluorescene Because only Dsg3, and not other desmo-
somal molecules, was depleted from cytoskeleton fractions 30 h
after the treatment with PV-IgG as revealed by immunoblotting,
we then determined whether this was morphologically observed
using immunofluorescence microscopy. After treated with 1%
Triton X-100, the PV-IgG stimulated cells cultured on the glass
coverslips were double-stained with anti-Dsg3 antibody (PV-IgG)
Figure 3. Double-staining immuno-
fluorescence microscopy of DJM-1 cells
stimulated with PV-IgG for 20 min using
anti-keratin 8 (a), anti-Dsg1 (c), anti-
Dpk1 (e), anti-PG (g), and Dsg3 (b, d, f,
h) antibodies. Cells were fixed with cold
methanol (–20°C) for 10 min. Dsg3 are
colocalized with any of Dsg1, Dpk1, and
PG.
and one of the monoclonal antibodies against Dsg1, PG, Dpk1,
and cytokeratin 8.
Double-immunofluorescence analysis using anti-Dsg3 (PV-IgG)
and monoclonal antibody-directed cytokeratin 8 showed that, in
the cells stimulated with PV-IgG for 20 min, Dsg3 was localized,
forming a punctate line at cell–cell contacts to which bundles of
keratin intermediate filaments (KIF) emanating from the juxta
nuclear region were bound, illustrating a radial organization in the
cell (Fig 3). In cells double-stained with anti-Dsg3 and one of
anti-Dsg1, anti-Dpk1, and anti-PG antibodies, the proteins were
colocalized along the plasma membrane generating a punctate or
linear line, whereas staining of PG revealed a more linear rather
than punctate line (Fig 3). These findings were the same as
observed in control cells treated with normal IgG for 20 min (not
shown). It should be noted that Dsg3 was found to be colocalized
with any of these desmosomal proteins as expected by immunoblot-
ting analysis, which showed that Dsg3 was not depleted from the
cytoskeleton, but was deleted from membrane fractions 20 min
after PV-IgG stimulation as shown by immunoblotting.
In contrast, in most of the cells incubated with PV-IgG for 30 h,
double-staining with anti-Dsg3 and anti-cytokeratin antibodies
revealed that Dsg3 disappeared dramatically from the cell–cell
contacts, which were still retained as shown by anti-keratin staining,
in the peripheral cells of the colony. This was less prominent in
the center of the colony (Fig 4c, d). The disappearance of Dsg3 was
more clearly demonstrated by double-label immunofluorescence
staining using anti-Dpk1 and Dsg3. Even after 30 h stimulation
with PV-IgG, Dpk1 maintained a punctate linear distribution
pattern at cell–cell contacts, whereas Dsg3 disappeared dramatically
from many of the cell–cell contacts (Fig 4k, l). The same results
were obtained in cells stained by double-label immunofluorescence
with anti-Dsg3 and any of the monoclonal antibodies directed to
Dsg1 and PG (Fig 4g, h, o, p). In cells treated with normal human
IgG, Dsg3 remained in a linear arrangement along cell–cell contacts
(Fig 4b, f, j, n). All these results demonstrate that 30 h stimulation
with PV-IgG markedly deleted Dsg3, but not other desmosomal
components, i.e., Dsg1, PG, and Dpk1, from desmosomes, to
which KIF were still bound.
DISCUSSION
An intriguing finding in this study is that the PV-IgG binding to
Dsg3 on the cell surface caused a marked reduction of only Dsg3,
and not Dsg1, Dpk1, and PG, from the membrane (Triton X-100
soluble) fraction early on, i.e., after 20 min, and also from the
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Figure 4. Double-staining immuno-
fluorescence microscopy of DJM-1 cells
stimulated with PV-IgG (c, d, g, h, k, l,
o, p) or normal IgG (a, b, e, f, i, j, m, n)
for 30 h using anti-keratin 8 (a, c), anti-
Dsg1 (e, g), anti-Dpk1 (i, k), anti-PG
(m, o), and Dsg3 (b, d, f, h, i, l, n,
p) antibodies. Cells were fixed with cold
methanol (–20°C) for 10 min. Note that
the number of immunofluorescent points of
Dsg3 was dramatically reduced from the
majority of points (desmosomes) where
keratin intermediate filaments are connected
point-to-point with each other 30 h after
stimulation with PV-IgG (c, d), whereas Dsg3
is clearly detected at cell–cell contacts,
forming a linear fluorescence 30 h after
normal IgG stimulation (a, b). Small arrows
(d) indicate remnants of Dsg3 at desmosornes,
whereas arrowheads indicate the points where
no Dsg3 is detected at joints of bundles of
keratin intermediate filaments (c, d). Dsg3 (h,
l, p; arrowheads) is dramatically deleted from
desmosomes where Dsg1 (g; arrowheads),
Dpk1 (k; arrowheads), and PG (p; arrowheads)
are clearly detected in samples obtained 30 h
after PV-IgG stimulation. A deletion or a
marked reduction in the fluorescence
intensity of Dsg3 (d, h, l, p) was also clearly
demonstrated 30 h after PV-IgG stimulation,
as compared with cells treated with normal
IgG (b, f, j, n).
cytoskeleton (Triton X-100 insoluble) fraction, which includes
desmosomes, later on, i.e., 30 h after stimulation with PV-IgG, as
revealed by immunoblotting analysis.
Because the depletion of Dsg3 from the Triton X-100 insoluble
cytoskeleton fraction was generated 30 h after the earlier (20–
60 min) deletion of Dsg3 from a Triton X-100 soluble pool after
PV-IgG stimulation, the depletion of Dsg3 from the cytoskeleton
fraction may be caused by a shortage of the Dsg3 pool for its
integration into desmosomes.
It is also of great interest to note that the depletion of Dsg3 from
the Triton X-100 insoluble (cytoskeletons including desmosomes)
fraction revealed by immunoblotting turned out to be that from
desmosomes, when determined by double-staining immunofluo-
rescence microscopy using anti-Dsg3 antibodies and one of the
monoclonal antibodies against desmosomal molecules and keratin
8. It was also consistent with immunoblotting analysis that the PV-
IgG-induced depletion of desmosomal constituents was limited to
Dsg3, whereas other components, i.e., Dsg1, Dpk1, and PG, were
retained to be intact in desmosomes even 30 h after PV-IgG
stimulation by immunofluorescence analysis. Another surprising
finding was that, even though almost all Dsg3 was depleted from
desmosomes in the peripheral cells of the colony, KIF were still
connected to desmosomes as revealed by double-staining with
monoclonal anti-keratin antibody. The Dsg3-depleted desmosomes
appear to maintain the integrity well enough to keep the cell–cell
contact associated with KIF at least in culture.
The fact that the depletion of Dsg3 from desmosomes was
prominent in the periphery of the colony, whereas it was not
always observed in the center of the colonies, may be due to the
shorter turnover time of desmosomes, which are more likely to
take place in the periphery of the colony, where cell migration and
proliferation are higher in activity, than in the center of the colony.
The turnover time in the periphery of the colony is supposed to
be short enough to visualize a formation of the Dsg-3 deleted
desmosomes because of the shortage of Dsg3 after 30 h PV-IgG
stimulation. The reason Dsg3 was found at desmosomes 20 min
after PV-IgG stimulation, is that 20 min may not be long enough
to replace the old pre-existing desmosomes with newly formed
Dsg3-deleted desmosomes.
Considering the function of Dsg3, i.e., binding to PG and KIF,
it is of interest to note that the deletion of Dsg3 did not particularly
affect the KIF binding to desmosomes. This suggests that other
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components compensate for KIF binding to desmosomes and
desmosomal integrity to a certain extent. The cell–cell adhesion
by Dsg3-deleted desmosomes, however, may not to be strong
enough to maintain the normal strength of the epidermis, and may
be a key cause for blistering in PV, as Dsg3-knockout mouse
showed a phenotype with blistering along the suprabasal layer,
similar to PV (Koch et al, 1997). Even if depletion of Dsg3 is
incomplete, it may be pathogenic as seen in transgenic mice with
N-terminal truncated Dsg3 gene, which generated widening of
intercellular spaces, a reduction of the number of desmosomes, and
aberrant desmosomes (Allen et al, 1996).
Expression of the desmoglein isoforms correlates well with
epidermal differentiation. It has been experimentally shown that
Dsg1 is strongly expressed in the upper layers of the epidermis,
whereas Dsg3 is predominantly expressed in the lower layers of
the epidermis, and Dsg2 is mainly expressed in the basal cells (Koch
et al, 1992; Arnemann et al, 1993; Shimizu et al, 1995; Amagai
et al, 1996; Schaefer et al, 1996). Regarding the function of Dsg3,
the expression of which is limited to the lower epidermis, it is very
interesting to note that Dsg3-knockout mouse showed a phenotype
with blistering along the suprabasal layer as seen in PV (Koch et al,
1997). These findings suggest that Dsg3 is required to maintain
structurally and functionally stable desmosomes. Taken together, it
may be reasonably speculated that the PV-IgG-induced depletion
of Dsg3 from desmosomes, as found in the present experimental
cell system, may be generated in the epidermis, and may also
represent a major cause of acantholysis in the lower epidermis of
PV patients. It is also intriguing to speculate that the failure of PV-
IgG to deplete Dsg1 from desmosomes is the most probable
explanation for the clinical features of PV. PV is characterized by
acantholyisis in the lower epidermis, but not in the upper epidermis
where Dsg1 expression is predominant.
In closing, our results showing that PV-IgG depleted only Dsg3,
and not other constituents, from desmosomes in cultured human
squamous cell carcinoma cell line cells, imply that PV-IgG-induced
depletion of Dsg3 from desmosomes may lead to cell–cell detach-
ment in the epidermis, especially in suprabasal layers where the
Dsg1/Dsg3 ratio is small.
This work was supported by grants from the Scientific Research Fund of the Ministry
of Education, Science, Sports and Culture, Japan (Grant-in-Aid for Scientific
Research no. 07407025 and 90291393), and by grants from the Ministry of
Health and Welfare, Japan.
REFERENCES
Allen E, Yu QC, Fuchs E: Mice expressing a mutant desmosomal cadherin exhibit
abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell
Biol 133:1367–1382, 1996
Amagai M: Adhesion molecules. Keratinocyte–keratinocytes interaction; cadherins
and pemphigus. J Invest Dermatol 104:146–152, 1995
Amagai M, Koch PJ, Nishikawa T, Stanley JR: Pemphigus vulgaris antigen
(Desmoglein 3) is localized in the lower epidermis, the site of blister formation
in patients. J Invest Dennatol 106:351–355, 1996
Andrew P, Kowalezyk AP, Anderson JE, Bougwardt JE, Hashimoto T, Stanley JR,
Green KJ: Pemphigus sera recognize conformationally sensitive epitopes in the
aminoterminal regions of desmogelin-l. J Invest Dermatol 105:147–152, 1995
Arnemann Sullivan KH, Magee AI, King IA, Buxton RS: Stratification related
expression of isoforms of the desmosomal cadherins in human epidermis.
J Cell Sci 104:741–750, 1993
Buxton RS, Cowin P, Franke WW, et al: Nomenclature of desmosomal cadherins.
J Cell Biol 121:481–483, 1993
Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y: Pharmacologic evidence for
involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-
trisphosphate generation, intracellular calcium increase, and plasminogen
activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest
Dermatol 105:329–333, 1995
Eyre RW, Stanley JR: Identification of pemphigus vulgaris antigen extracted from
normal human epidermis and comparison with pemphigus foliaceus antigen.
J Clin Invest 81:807–812, 1988
Hashimoto K, Shafran KM, Webber PA, Lazarus GS, Singer KH: Anti-cell surface
pemphigus antibody stimulates plasminogen activator activity of human
epidermal cells. A mechanism for the loss of epidermal cohesion and blister
formation. J Exp Med 157:259–272, 1983
Hashimoto T, Ogawa MM, Konohana A, Nishikawa T: Detection of pemphigus
vulgaris and pemphigus foliaceus antigens by immunoblot analysis using
different antigen sources. J Invest Dermatol 94:327–331, 1990
Karpati S, Amagai M, Prussick R, Cehrs K, Stanley JR: Pemphigus vulgaris antigen,
a desmoglein type of cadherin, is located within keratinocyte desmosomes.
J Cell Biol 122:409–415, 1993
Kitajima Y: Adhesion molecules in the pathophysiology of bullous deseases. Eur J
Dermatol 6:399–405, 1996
Kitajima Y, Inoue S, Yaoita H: Effects of pemphigus antibody on the regeneration
of cell-cell contact in keratinocyte culture grown in low to normal Ca11
concentration. J Invest Dermatol 89:167–171, 1987
Kitajima Y, Inoue S, Nagao S, Nagata K, Yaoita H, Nozawa Y: Biphasic effects of
12-0-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-
grown human epidermal carcinoma cells: involvement of translocation and
down regulation of protein kinase C. Cancer Res 48:964–970, 1988
Koch PJ, Goldschmidt MD, Walsh MJ, Zimbelmann R, Troyanoysky R, Franke
WW: Complexity and expression patterns of the desmosomal cadherins. Proc
Nad Acad Sci USA 89:353–357, 1992
Koch PJ, Mahoney MG, Ishikawa H, et al: Targeted disruption of the pemphigus
vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell
adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091–
1102, 1997
Korman N, Eyre RW, Klau-kovtun V, Stanley JR: Demonstration of an adhering
junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus
and pemphigus vulgaris. N Engl Med 321:631–635, 1985
Koulu L, Kusurni A, Steinberg MS, Klaus-Kovturn V, Stanley JR: Human
autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp
Med 160:1509–1518, 1984
Laemmli UK: Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature 227:680–685, 1970
Morioka S, Naito K, Ogawa H: The pathogenic role of pemphigus antibodies and
proteinase in epidermal acantholysis. J Invest Dernatol 76:337–341, 1981
Osada K, Seishirna M, Kitajima Y: Pemphigus IgG activates and translocates protein
kinase C from the cytosol to the particulate/cytoskeleton fractions in human
keratinocytes. J Invest Dermatol 108:482–487, 1997
Schaefer S, Stump S, Franke WW: Immunological identification and characterization
of the desmosomal cadherin Dsg2 in coupled and uncoupled epithelial cells
and in human tissues. Differentiation 60:99–108, 1996
Seishima M, Osada K, Mori S, Hashimoto T, Kitajima Y: Pemphigus IgG, but not
bullous pemphigoid IgG, causes a transient increase in intracellular calcium
and inositol 1,4,5-trisphosphate in DJM-1 cells, a squamous cell carcinoma
line. J Invest Dermatol 104:33–37, 1995
Seishima M, Satoh S, Nojifi M, Osada K, Kitajima Y: Pemphigus IgG induces
expression of urokinase plasminogen activator receptor on the cell surface of
cultured keratinocytes. J Invest Dermatol 109:650–655, 1997
Shimizu H, Masunaga T, Ishilco A, Kikuchi A, Hashimoto T, Nishikawa T:
Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded
binding pattern to Extracellular regions of desmosomes in different layers of
human epidermis. J Invest Dermatol 105:153–159, 1995
